Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.64ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.64NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.68ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.68NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.65 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.65 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.65 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.65 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.466ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.466ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
L.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
L.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
L.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.339ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.339ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.339ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.339NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.229ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.229ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.229ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.229NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.415ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.415ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.415ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.415NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.370ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.370ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.370ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.370NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.421ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.421ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.421ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.421NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.428.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.428.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.612ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.612ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.612ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.612NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.305ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.305ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used